What is the URGN stock price prediction for next 2 weeks?

According to our price prediction algorithm,UroGen Pharma Ltd. (URGN) price will be around $43.50 in the next 2 weeks. This means it will increase by 14.384959242703122 from the last closing price. This prediction may vary from other time period filters for URGN stock.

What can be the highest Possible price of URGN stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, URGN can achieve the highest price of $44.70 which is 17.533197942031823 higher than last closing price. This prediction may vary from other time period filters for URGN stock.

What can be the lowest Possible price of URGN stock in next 2 weeks?

As per the forecast and algorithmic analysis, URGN stock price can be as low as $42.30 which is 11.236989035278148 higher than the current price in the next 2 weeks. This prediction may vary from other time period filters for URGN stock.

Will URGN stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that URGN stock will gain14.384959242703122 in the next 2 weeks. This prediction may vary from other time period filters for URGN stock.

What is URGN stock last closing price?

Last closing price of URGN stock was $40.23.

What is URGN stock price prediction?

URGN stock price prediction means predicting the future closing prices of URGN stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of URGN stock in a certain time period.

How we predict URGN stock future prices?

If you are searching for URGN stock forecast, analysis or price prediction, then you might be wondering what UroGen Pharma Ltd. (URGN) will do in the future. Our URGN price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This URGN price prediction will likely answer most of your questions.

How frequent we update URGN stock predictions?

We are updating the forecasts for the URGN stock on daily basis.

Is using ML forecasting for URGN stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for URGN stock same for all the time periods?

No, the prediction for URGN stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

UroGen Pharma Ltd. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$40.2317.02%Since 2 Weeks

Predicted Price$43.5014.38%For 2 Weeks

Upper Predicted Price$44.7017.53%For 2 Weeks

Lower Predicted Price$42.3011.24%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of URGN will rise by +14.38% over the next 2 Weeks and hit $43.50 by Wednesday, July 22, 2026. In that time frame, URGN's share price is expected to range between $42.30 and $44.70.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jul 22, 2026	42.30	43.50	44.70
Jul 21, 2026	41.88	42.96	44.10
Jul 20, 2026	40.91	41.87	42.97
Jul 17, 2026	39.86	40.87	41.91
Jul 16, 2026	40.34	41.24	42.28
Jul 15, 2026	39.87	40.83	41.80
Jul 14, 2026	39.37	40.29	41.16
Jul 13, 2026	38.28	39.20	40.11
Jul 10, 2026	37.36	38.20	39.14
Jul 9, 2026	37.64	38.57	39.51

URGN shares rose +5.78% in Thursday, July 9, 2026's trading session, rising from a previous close of $38.03 to move at $40.23. The stock demonstrated notable intraday movement (see URGN's key stats for a full breakdown), fluctuating between $38.11 and $40.32, a +5.80% trading range. While recent weeks have seen some volatility, URGN has managed to secure a +17.02% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 616.4K shares changing hands, 85.98K fewer than the previous session. This amounted to $24.80M in total market activity.

Will URGN Continue Its Upward Trend?

According to analyst ratings and projections for URGN, UroGen Pharma Ltd. shares are anticipated to increase by +10.00%, potentially reaching $44.70 per share by July 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for URGN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 21 positive trading days within the past 30 sessions. Based on the URGN stock forecast, now is a good time to buy URGN stock because its current trading price is -7.52% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on URGN covering social and institutional perspectives.

URGN Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into URGN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 76.50% to 85.01%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 66.98%, suggests strong medium-term momentum. However, the 100-day RSI, at 61.57%, points to growing bullish momentum over the long term. Insights into URGN's shareholder base show how institutional investors are positioning themselves during these momentum shifts

UroGen Pharma Short-Term Forecasts

URGN Forecast For Next 5 Days

Our algorithm anticipates UroGen Pharma (URGN) stock could hit $40.40 by Jul 16, 2026. This represents a +0.42% fall from today's price, following a -9.88% change over the past five days.

URGN Forecast For Next 30 Days

Based on analysis of market trends, the outlook for UroGen Pharma Ltd. (URGN) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $41.76, which would mean a +3.80% increase from the current price of $40.23. Projections for this period range from a high of $46.52 to a low of $35.02.

URGN Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for UroGen Pharma's price over the next three months point to a drop. URGN stock is expected to peak at $39.97 on Oct 09, 2026 after potentially dipping to $33.87 on Aug 27, 2026. On average, URGN is likely to trade around $36.90 in the coming 90 days.

UroGen Pharma Stock Forecast 2025

Based on our predictive models, UroGen Pharma (URGN) is expected to trade between $33.87 and $42.21 throughout 2026. This would result in an average price of $37.77, potentially offering investors a -6.11% return from current levels.

UroGen Pharma Ltd. Monthly Forecast 2026–2027

July 2026

According to our latest forecast models, UroGen Pharma Ltd. (URGN) is positioned to show a strong performance in July 2026. The price is predicted to move between $35.02 and $39.73, settling at an average of $37.18. This could translate to a -7.58% loss.

August 2026

Based on current market signals, UroGen Pharma Ltd. is projected to trend august 2026. We forecast a trading range from $33.87 to $38.81, with a likely average price of $36.26. Investors could expect a potential return of -9.87%.

September 2026

Our predictive algorithms indicate UroGen Pharma Ltd. stock may see a shift in September 2026. The expected range spans $34.32–$39.28, with an average target of $37.02. This represents a cautious outlook and a possible loss of -7.98%.

October 2026

Analyzing established trends, UroGen Pharma Ltd. looks set to move in October 2026. Projections place the stock between $35.53 and $40.05, averaging around $37.87. This suggests a -5.87% loss from current levels.

November 2026

Market indicators suggest UroGen Pharma Ltd. could experience notable changes during November 2026. Prices could fluctuate within $36.04 to $42.21, with a midpoint forecast of $39.47. The stock might deliver a -1.89% loss.

December 2026

Forecasting for December 2026, models estimate that UroGen Pharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $36.19 and $41.75, averaging $38.63. This signals a cautious trajectory with potential returns around -3.98%.

January 2027

According to our latest forecast models, UroGen Pharma Ltd. (URGN) is positioned to show a strong performance in January 2027. The price is predicted to move between $35.34 and $40.00, settling at an average of $37.47. This could translate to a -6.86% loss.

February 2027

Based on current market signals, UroGen Pharma Ltd. is projected to trend february 2027. We forecast a trading range from $35.66 to $40.84, with a likely average price of $38.42. Investors could expect a potential return of -4.50%.

March 2027

Our predictive algorithms indicate UroGen Pharma Ltd. stock may see a shift in March 2027. The expected range spans $36.81–$41.58, with an average target of $39.19. This represents a cautious outlook and a possible loss of -2.59%.

April 2027

Analyzing established trends, UroGen Pharma Ltd. looks set to move in April 2027. Projections place the stock between $37.37 and $43.42, averaging around $40.84. This suggests a +1.52% gain from current levels.

May 2027

Market indicators suggest UroGen Pharma Ltd. could experience notable changes during May 2027. Prices could fluctuate within $37.63 to $42.37, with a midpoint forecast of $39.81. The stock might deliver a -1.04% loss.

June 2027

Forecasting for June 2027, models estimate that UroGen Pharma Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $36.24 and $41.04, averaging $38.78. This signals a cautious trajectory with potential returns around -3.60%.

July 2027

According to our latest forecast models, UroGen Pharma Ltd. (URGN) is positioned to show a strong performance in July 2027. The price is predicted to move between $36.84 and $41.41, settling at an average of $39.29. This could translate to a -2.34% loss.

URGN's history of dividends and stock splits also plays a role in long-term investor confidence.